ZENGLOW
BPC-157 + TB-500 + GHK-Cu
(BPC-157: 3.33 mg/mL + TB-500: 3.33 mg/mL + GHK-Cu: 16.67 mg/mL)
- Dermal repair and regeneration signaling
- Collagen, elastin, and extracellular-matrix support pathways
- Soft-tissue and connective-tissue recovery models
- Wound-healing and tissue-remodeling pathway activity
- Inflammatory response modulation in research models
Ships FREE from within Canada · No customs · no border delays.
Please check the box above to continue.
OVERVIEW
A three-peptide blend studied in skin and repair research.
ZENGLOW combines BPC-157 and TB-500, two peptides studied in tissue-repair models, with GHK-Cu, a copper-binding tripeptide studied in skin and extracellular-matrix remodelling. The blend is studied for tissue-repair signalling, inflammatory modulation and dermal connective support.
Research interest spans angiogenic and endothelial signalling, cytoskeletal and cell-migration pathways, and collagen / ECM remodelling.
ZENGLOW is a research-grade formulation, not an authorized medicine, and Zenovate makes no claim about cosmetic or therapeutic effects in humans. Every batch is synthesized to a written specification and tested for identity, purity and stability by an independent accredited laboratory before it is listed.
SPECIFICATIONS
THE RESEARCH
Cited research areas: angiogenic / endothelial (BPC-157) and cytoskeletal (TB-500) signalling; collagen and ECM remodelling (GHK-Cu); peptide stability and formulation chemistry.
We cite the literature. We make no claims about effects or outcomes, and no comparison to prescription products.
TESTING & QUALITY ASSURANCE
Every batch is tested before it ships.
COMPOUND FAQ
Questions specific to ZENGLOW.
Is ZENGLOW a prescription medicine?
No. ZENGLOW is a research-grade formulation with no marketing authorization in Canada; it is not a medicine and not a substitute for one.
How do I verify what is in a ZENGLOW vial?
Every batch is tested for identity, purity and stability by an independent accredited laboratory using UPLC / HPLC, LC-MS and related methods. Our full testing methodology is published on the Lab Results page.
Why does Zenovate avoid naming prescription brands?
Because comparing a research compound to an authorized medicine would be both misleading and non-compliant; they are different categories held to different standards of evidence.
RELATED FORMULATIONS
More from the lineup.
Compounded products are not evaluated by Health Canada for safety, effectiveness or quality. ZENGLOW is a research-grade formulation, not a medicine, and nothing on this page is medical advice. For adults 19 and older.